PT - JOURNAL ARTICLE AU - Katherine Leggat-Barr AU - Fumiya Uchikoshi AU - Noreen Goldman TI - COVID-19 Risk Factors and Mortality among Native Americans AID - 10.1101/2021.03.13.21253515 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.13.21253515 4099 - http://medrxiv.org/content/early/2021/10/15/2021.03.13.21253515.short 4100 - http://medrxiv.org/content/early/2021/10/15/2021.03.13.21253515.full AB - BACKGROUND Academic research on the disproportionate impact of COVID-19 among Native Americans has largely been restricted to particular indigenous groups or reservations.OBJECTIVE We estimate COVID-19 mortality for Native Americans relative to other racial/ethnic groups and explore how state-level mortality is associated with known risk factors. METHODS: We use the Standard Mortality Ratio (SMR), adjusted for age, to estimate COVID-19 mortality by racial/ethnic groups for the U.S. and 16 selected states that account for three-quarters of the Native American population. The prevalence of risk factors is derived from the American Community Survey and the Behavioral Risk Factor Surveillance System.RESULTS The SMR for Native Americans greatly exceeds those for Black and Latino populations and varies enormously across states. There is a strong positive correlation across states between the share of Native Americans living on a reservation and the SMR. The SMR for Native Americans is highly correlated with the income-poverty ratio, the prevalence of multigenerational families, and health insurance (excluding the Indian Health Service). Risk factors associated with socioeconomic status and co-morbidities are generally more prevalent for Native Americans living on homelands, a proxy for reservation status, than for those living elsewhere.CONCLUSIONS Most risk factors for COVID-19 are disproportionately high among Native Americans. Reservation life appears to increase the risk of COVID-19 mortality.CONTRIBUTION We assemble and analyze a broader set of COVID-19-related risk factors for Native Americans than previous studies, a critical step toward understanding the exceptionally high COVID-19 death rates in this population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPrinceton University provided summer internship support for Katherine Leggat-Barr.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Princeton University IRB determined that this research, which consists of secondary analysis of publicly available data, does not constitute human subjects research and was therefore not subject to IRB approval.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available through websites of the CDC, US Census, ACS and BRFSS.